Australian Medical Association
The Department of Health has advised the AMA that some prescriptions have been issued to patients with incorrect information as a result of software provider errors in relation to Active Ingredient Prescribing (AIP).
Prescription errors have included printing out several strength options, the wrong strength, or no strength at all.
Members are advised to double check their patient’s prescription once it has been printed to ensure it is correct, and to ensure they have the most recent version of their software updated.
The AMA and the Department of Health want to hear about any issues you are experiencing due to the implementation of AIP.
Date Time
Active Prescribing – Coming 1 Feb 2021
As of 1 February 2021, all eligible PBS and RPBS prescriptions will need to include the active ingredient, followed by brand if the prescriber believes it is clinically necessary.
The goal of Active Ingredient Prescribing is to help people understand what medicines they are taking. Under new medicine regulations, doctors must include the active ingredient names when preparing prescriptions for Pharmaceutical Benefits Scheme (PBS) and Repatriation PBS (RPBS) medicines. This will mean most medicines will be prescribed by their active ingredient, not the brand name.
The Department of Health has changed legislation to require the inclusion of active ingredients on all PBS and RPBS prescriptions, except for: